1. Home
  2. SPXC vs GRFS Comparison

SPXC vs GRFS Comparison

Compare SPXC & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPXC
  • GRFS
  • Stock Information
  • Founded
  • SPXC 1912
  • GRFS 1940
  • Country
  • SPXC United States
  • GRFS Spain
  • Employees
  • SPXC N/A
  • GRFS N/A
  • Industry
  • SPXC Industrial Machinery/Components
  • GRFS Biotechnology: Pharmaceutical Preparations
  • Sector
  • SPXC Industrials
  • GRFS Health Care
  • Exchange
  • SPXC Nasdaq
  • GRFS Nasdaq
  • Market Cap
  • SPXC 7.8B
  • GRFS 6.2B
  • IPO Year
  • SPXC N/A
  • GRFS 2006
  • Fundamental
  • Price
  • SPXC $170.89
  • GRFS $9.77
  • Analyst Decision
  • SPXC Strong Buy
  • GRFS Hold
  • Analyst Count
  • SPXC 4
  • GRFS 1
  • Target Price
  • SPXC $193.25
  • GRFS $10.30
  • AVG Volume (30 Days)
  • SPXC 249.4K
  • GRFS 803.4K
  • Earning Date
  • SPXC 07-31-2025
  • GRFS 01-01-0001
  • Dividend Yield
  • SPXC N/A
  • GRFS N/A
  • EPS Growth
  • SPXC 109.74
  • GRFS N/A
  • EPS
  • SPXC 4.31
  • GRFS 0.31
  • Revenue
  • SPXC $2,001,300,000.00
  • GRFS $7,968,532,207.00
  • Revenue This Year
  • SPXC $13.77
  • GRFS $7.14
  • Revenue Next Year
  • SPXC $7.27
  • GRFS $7.16
  • P/E Ratio
  • SPXC $40.18
  • GRFS $39.05
  • Revenue Growth
  • SPXC 10.78
  • GRFS 10.76
  • 52 Week Low
  • SPXC $115.00
  • GRFS $6.19
  • 52 Week High
  • SPXC $183.83
  • GRFS $10.00
  • Technical
  • Relative Strength Index (RSI)
  • SPXC 61.51
  • GRFS 70.91
  • Support Level
  • SPXC $169.78
  • GRFS $9.70
  • Resistance Level
  • SPXC $174.56
  • GRFS $9.91
  • Average True Range (ATR)
  • SPXC 3.66
  • GRFS 0.21
  • MACD
  • SPXC 0.01
  • GRFS 0.06
  • Stochastic Oscillator
  • SPXC 68.53
  • GRFS 85.26

About SPXC SPX Technologies Inc.

SPX Technologies Inc supplies engineered heating, ventilation, and air conditioning, or HVAC, products, as well as detection and measurement technologies and power equipment. The company through two reportable segments. The HVAC segment which generates the majority of the revenue for the company, designs, manufactures, installs, and services cooling products, as well as heating and ventilation products. The detection and measurement technologies segment designs, manufactures, and installs underground pipe and cable locators and inspection equipment, bus-fare collection systems, and others. Geographically, the company has its operations in the United States, Canada, China, the United Kingdom, and Others.

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

Share on Social Networks: